FDA Inspection
Joseph Thaddeus Beck, MDFDA Inspection 1130823 - Joseph Thaddeus Beck, MD - October 02, 2020
Record Details
This FDA Inspection record concerns Joseph Thaddeus Beck, MD, with an inspection on October 2, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Joseph Thaddeus Beck, MD
- Inspection Date
- October 2, 2020
- Product Type
- Drugs
View Company Profile
ID · 7f3fefe3-b4db-4a6b-89c8-b147c12cee1b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1130823
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Joseph Thaddeus Beck, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 16, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 19, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Joseph Thaddeus Beck, MD
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.